A large international study of Chantix and GlaxoSmithKline’s ($GSK) Zyban found that the meds do not increase patients’ risks of neuropsychiatric side effects. The meds also beat a nicotine patch and placebo at helping people quit smoking, according to results recently published in The Lancet.
One small little detail not mentioned in the article…… The study was funded by Pfizer and GSK.
Yeah.
Listen to the hilarity here:
